ABCG2 and cancer: While various ABC transporter inhibitors have been shown to sensitize drug-resistant colon cancer cells to chemotherapy drugs in experimental models [98,99,100,101], the development of PGP as a therapeutic target for cancer in general has not been successful clinically [42].